Literature DB >> 1705638

Positive and negative effects of tumor necrosis factor on colony growth from highly purified normal marrow progenitors.

B Backx1, L Broeders, F J Bot, B Löwenberg.   

Abstract

The effects of recombinant human tumor necrosis factor alpha (TNF alpha) on colony growth were studied using highly enriched progenitor cells from normal human bone marrow. Supplementation of TNF to culture resulted in a dose-dependent suppression of granulocyte colony-stimulating factor (G-CSF) induced granulocytic colony formation and also erythropoietin (Epo) induced erythroid burst formation. However, the number of erythroid bursts, stimulated by interleukin-3 (IL-3) plus Epo, increased when TNF was added at comparable concentrations. Further, TNF enhanced eosinophilic colony growth induced by IL-3 or granulocytic-macrophage colony-stimulating factor (GM-CSF). In GM-CSF cultures TNF (100-1000 U/ml) also induced granulocytic and macrophage colonies. The addition of neutralizing antibodies against G-CSF, GM-CSF, or interleukin-6 (IL-6) to culture did not abrogate the observed effects of TNF, so that stimulation of myeloid colony growth was unlikely to result from the secondary induction of G-CSF or GM-CSF. TNF therefore exerts favourable effects on hematopoietic progenitors responsive to the more primitive colony-stimulating factors (IL-3, GM-CSF) and potent negative effects on precursors reactive to the single lineage G-CSF and Epo. These contrasting effects of TNF suggest that TNF, when available to marrow progenitors at similar tissue concentrations, may drive hematopoiesis within the progenitor cell compartment into selected directions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1705638

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  8 in total

Review 1.  Interaction of inflammatory cytokines and erythropoeitin in iron metabolism and erythropoiesis in anaemia of chronic disease.

Authors:  M Jongen-Lavrencic; H R Peeters; G Vreugdenhil; A J Swaak
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

2.  Delayed addition of tumor necrosis factor (TNF) antagonists inhibits the generation of CD11c+ dendritic cells derived from CD34+ cells exposed to TNF-alpha.

Authors:  Yong-Mei Guo; Makoto Hirokawa; Naoto Takahashi; Masumi Fujishima; Naohito Fujishima; Atsushi Komatsuda; Hiroyuki Tagawa; Hideaki Ohyagi; Yoshihiro Michishita; Kumi Ubukawa; Miwa Hebiguchi; Weiguo Xiao; Kenichi Sawada
Journal:  Int J Hematol       Date:  2009-12-12       Impact factor: 2.490

3.  R-h-erythropoietin counteracts the inhibition of in vitro erythropoiesis by tumour necrosis factor alpha in patients with rheumatoid arthritis.

Authors:  M Jongen-Lavrencic; H R Peeters; B Backx; I P Touw; G Vreugdenhil; A J Swaak
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

4.  Tumor necrosis factor-alpha inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. Role of p55 and p75 tumor necrosis factor receptors.

Authors:  L S Rusten; E B Smeland; F W Jacobsen; E Lien; W Lesslauer; H Loetscher; C M Dubois; S E Jacobsen
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

5.  Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia.

Authors:  F Dong; L H Hoefsloot; A M Schelen; C A Broeders; Y Meijer; A J Veerman; I P Touw; B Löwenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

Review 6.  Ineffective erythropoiesis in β -thalassemia.

Authors:  Jean-Antoine Ribeil; Jean-Benoit Arlet; Michael Dussiot; Ivan Cruz Moura; Geneviève Courtois; Olivier Hermine
Journal:  ScientificWorldJournal       Date:  2013-03-28

Review 7.  Role of Extrinsic Apoptotic Signaling Pathway during Definitive Erythropoiesis in Normal Patients and in Patients with β-Thalassemia.

Authors:  Olga Raducka-Jaszul; Dżamila M Bogusławska; Natalia Jędruchniewicz; Aleksander F Sikorski
Journal:  Int J Mol Sci       Date:  2020-05-08       Impact factor: 5.923

8.  A DL-4- and TNFα-based culture system to generate high numbers of nonmodified or genetically modified immunotherapeutic human T-lymphoid progenitors.

Authors:  Ranjita Devi Moirangthem; Kuiying Ma; Sabrina Lizot; Anne Cordesse; Juliette Olivré; Corinne de Chappedelaine; Akshay Joshi; Agata Cieslak; John Tchen; Nicolas Cagnard; Vahid Asnafi; Antonio Rausell; Laura Simons; Julien Zuber; Tom Taghon; Frank J T Staal; Françoise Pflumio; Emmanuelle Six; Marina Cavazzana; Chantal Lagresle-Peyrou; Tayebeh Soheili; Isabelle André
Journal:  Cell Mol Immunol       Date:  2021-06-11       Impact factor: 11.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.